Cerus Corp
NASDAQ:CERS
Cerus Corp
NASDAQ:CERS
Price:
1.72 USD
2.99%
Market Closed
Updated:
May 2, 2024
Cerus Corp
Operating Income
|
Cerus Corp
Operating Income Peer Comparison
Comparables:
HAE
COO
XRAY
ALGN
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cerus Corp
NASDAQ:CERS
|
Operating Income
-$26.3m
|
CAGR 3-Years
23%
|
CAGR 5-Years
14%
|
CAGR 10-Years
1%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Operating Income
$199.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Operating Income
$536.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Operating Income
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Income
$663.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
See Also
What is Cerus Corp's Operating Income?
Operating Income
-26.3m
USD
-26.3m
USD
Based on the financial report for Dec 31, 2023, Cerus Corp's Operating Income amounts to -26.3m USD.
What is Cerus Corp's Operating Income growth rate?
Operating Income CAGR 10Y
1%
1%
Over the last year, the Operating Income growth was 22%. The average annual Operating Income growth rates for Cerus Corp have been 23% over the past three years , 14% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
